Поисковый запрос: (<.>S=ОСТЕОКЛАСТОГЕНЕЗ<.>) |
Общее количество найденных документов : 104
Показаны документы с 1 по 20
|
|
1.
| Эпигенетические аспекты остеопороза // Вестн. РАМН, 2015, N 5.-С.541-548
|
2.
| Маркеры остеокластогенеза и остеобластогенеза при подострой интоксикации дихлорэтаном // Материалы научно-практической конференции с международным участием "Илизаровские чтения", Курган, 10-11 июня, 2015. -Курган, 2015.-С.155-156
|
3.
| Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis // Nature Med., 2012. Vol. 18, N 3.-С.405-412
|
4.
| Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling // J. Cell Biol., 2013. Vol. 200, N 6.-С.821-837
|
5.
| Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling // J. Cell Biol., 2013. Vol. 200, N 6.-С.821-837
|
6.
| Vitamin D[3] supports osteoclastogenesis via functional vitamin D response element of human RANKL gene promoter // J. Cell. Biochem., 2003. Vol. 89, N 4.-С.771-777
|
7.
| Tyrosine phosphorylation is required for I'каппа'B kinase-'бета' (IKK'бета') activation and function in osteoclastogenesis // J. Biol. Chem., 2010. Vol. 285, N 33.-С.25522-25530
|
8.
| Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis // J. Biol. Chem., 2000. Vol. 275, N 35.-С.27307-27310
|
9.
| Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis // J. Biol. Chem., 2000. Vol. 275, N 35.-С.27307-27310
|
10.
| Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood // Bone, 2000. Vol. 27, N 1.-С.47-52
|
11.
| Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood // Bone, 2000. Vol. 27, N 1.-С.47-52
|
12.
| The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression // J. Rheumatol., 2007. Vol. 34, N 5.-С.1058-1068
|
13.
| The synthetic triterpenoid TP-222 inhibits RANKL stimulation of osteoclastogenesis and matrix metalloproteinase-9 expression // J. Rheumatol., 2007. Vol. 34, N 5.-С.1058-1068
|
14.
| The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells // Prostate, 2010. Vol. 70, N 4.-С.412-424
|
15.
| The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells // Prostate, 2010. Vol. 70, N 4.-С.412-424
|
16.
| The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation // Biomaterials, 2013. Vol. 34, N 1.-С.150-159
|
17.
| The effect of adenovirus-mediated siRNA targeting BMPR-II on UHMWPE-induced osteoclast formation // Biomaterials, 2013. Vol. 34, N 1.-С.150-159
|
18.
| T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-'гамма' // Nature. -Gr. Brit., 2000. Vol. 408, N 6812.-С.600-605
|
19.
| Receptor activator of NF-kB (RANK) cytoplasmic IVVY{535-538} motif plays an essential role in tumor necrosis factor-'альфа' (TNF)-mediated osteoclastogenesis // J. Biol. Chem., 2010. Vol. 285, N 48.-С.37427-37435
|
20.
| Qin Calcitonin may be a useful therapeutic agent for osteoclastogenesis syndromes involving premature eruption of the tooth // Med. Hypotheses, 2008. Vol. 70, N 5.-С.1048-1050
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"